Intro

This chapter explores the implications of a newly passed bill during the Trump administration, focusing on both its beneficial and concerning elements. Key issues include potential risks associated with AI liability protections and ethical breaches in medical experimentation, alongside a call for public scrutiny of government surveillance practices.